125 related articles for article (PubMed ID: 11313091)
1. Divalproex sodium in sex offenders with bipolar disorders and comorbid paraphilias: an open retrospective study.
Nelson E; Brusman L; Holcomb J; Soutullo C; Beckman D; Welge JA; Kuppili N; McElroy SL
J Affect Disord; 2001 May; 64(2-3):249-55. PubMed ID: 11313091
[TBL] [Abstract][Full Text] [Related]
2. Divalproex utility in bipolar disorder with co-occurring cocaine dependence: a pilot study.
Salloum IM; Douaihy A; Cornelius JR; Kirisci L; Kelly TM; Hayes J
Addict Behav; 2007 Feb; 32(2):410-5. PubMed ID: 16814474
[TBL] [Abstract][Full Text] [Related]
3. Randomized, placebo-controlled trial of mixed amphetamine salts for symptoms of comorbid ADHD in pediatric bipolar disorder after mood stabilization with divalproex sodium.
Scheffer RE; Kowatch RA; Carmody T; Rush AJ
Am J Psychiatry; 2005 Jan; 162(1):58-64. PubMed ID: 15625202
[TBL] [Abstract][Full Text] [Related]
4. Impulsive aggression with irritability and responsive to divalproex: a pediatric bipolar spectrum disorder phenotype?
Barzman DH; McConville BJ; Masterson B; McElroy S; Sethuraman G; Moore K; Kahwaty AM; Nelson D
J Affect Disord; 2005 Nov; 88(3):279-85. PubMed ID: 16169087
[TBL] [Abstract][Full Text] [Related]
5. Psychiatric and legal features of 113 men convicted of sexual offenses.
Dunsieth NW; Nelson EB; Brusman-Lovins LA; Holcomb JL; Beckman D; Welge JA; Roby D; Taylor P; Soutullo CA; McElroy SL
J Clin Psychiatry; 2004 Mar; 65(3):293-300. PubMed ID: 15096066
[TBL] [Abstract][Full Text] [Related]
6. Valproic acid, valproate and divalproex in the maintenance treatment of bipolar disorder.
Macritchie KA; Geddes JR; Scott J; Haslam DR; Goodwin GM
Cochrane Database Syst Rev; 2001; (3):CD003196. PubMed ID: 11687047
[TBL] [Abstract][Full Text] [Related]
7. An open-label trial of divalproex in children and adolescents with bipolar disorder.
Wagner KD; Weller EB; Carlson GA; Sachs G; Biederman J; Frazier JA; Wozniak P; Tracy K; Weller RA; Bowden C
J Am Acad Child Adolesc Psychiatry; 2002 Oct; 41(10):1224-30. PubMed ID: 12364844
[TBL] [Abstract][Full Text] [Related]
8. Effect size of lithium, divalproex sodium, and carbamazepine in children and adolescents with bipolar disorder.
Kowatch RA; Suppes T; Carmody TJ; Bucci JP; Hume JH; Kromelis M; Emslie GJ; Weinberg WA; Rush AJ
J Am Acad Child Adolesc Psychiatry; 2000 Jun; 39(6):713-20. PubMed ID: 10846305
[TBL] [Abstract][Full Text] [Related]
9. Olanzapine-divalproex combination versus divalproex monotherapy in the treatment of bipolar mixed episodes: a double-blind, placebo-controlled study.
Houston JP; Tohen M; Degenhardt EK; Jamal HH; Liu LL; Ketter TA
J Clin Psychiatry; 2009 Nov; 70(11):1540-7. PubMed ID: 19778495
[TBL] [Abstract][Full Text] [Related]
10. Chart review of the impact of attention-deficit/hyperactivity disorder comorbidity on response to lithium or divalproex sodium in adolescent mania.
State RC; Frye MA; Altshuler LL; Strober M; DeAntonio M; Hwang S; Mintz J
J Clin Psychiatry; 2004 Aug; 65(8):1057-63. PubMed ID: 15323589
[TBL] [Abstract][Full Text] [Related]
11. Divalproex in the treatment of bipolar depression: a placebo-controlled study.
Davis LL; Bartolucci A; Petty F
J Affect Disord; 2005 Apr; 85(3):259-66. PubMed ID: 15780695
[TBL] [Abstract][Full Text] [Related]
12. Randomized, double-blind, placebo-controlled study of divalproex extended release loading monotherapy in ambulatory bipolar spectrum disorder patients with moderate-to-severe hypomania or mild mania.
McElroy SL; Martens BE; Creech RS; Welge JA; Jefferson L; Guerdjikova AI; Keck PE
J Clin Psychiatry; 2010 May; 71(5):557-65. PubMed ID: 20361901
[TBL] [Abstract][Full Text] [Related]
13. Divalproex in the treatment of acute bipolar depression: a preliminary double-blind, randomized, placebo-controlled pilot study.
Ghaemi SN; Gilmer WS; Goldberg JF; Zablotsky B; Kemp DE; Kelley ME; Bauer AD; Fleck J; Filkowski MM; Stan VA; Dunn RT
J Clin Psychiatry; 2007 Dec; 68(12):1840-4. PubMed ID: 18162014
[TBL] [Abstract][Full Text] [Related]
14. Long-term naturalistic treatment of depressive symptoms in bipolar illness with divalproex vs. lithium in the setting of minimal antidepressant use.
Ghaemi SN; Goodwin FK
J Affect Disord; 2001 Aug; 65(3):281-7. PubMed ID: 11511408
[TBL] [Abstract][Full Text] [Related]
15. The efficacy and tolerability of quetiapine versus divalproex for the treatment of impulsivity and reactive aggression in adolescents with co-occurring bipolar disorder and disruptive behavior disorder(s).
Barzman DH; DelBello MP; Adler CM; Stanford KE; Strakowski SM
J Child Adolesc Psychopharmacol; 2006 Dec; 16(6):665-70. PubMed ID: 17201610
[TBL] [Abstract][Full Text] [Related]
16. A randomized, placebo-controlled 12-month trial of divalproex and lithium in treatment of outpatients with bipolar I disorder. Divalproex Maintenance Study Group.
Bowden CL; Calabrese JR; McElroy SL; Gyulai L; Wassef A; Petty F; Pope HG; Chou JC; Keck PE; Rhodes LJ; Swann AC; Hirschfeld RM; Wozniak PJ
Arch Gen Psychiatry; 2000 May; 57(5):481-9. PubMed ID: 10807488
[TBL] [Abstract][Full Text] [Related]
17. A randomized, placebo-controlled, multicenter study of divalproex sodium extended-release in the acute treatment of mania.
Hirschfeld RM; Bowden CL; Vigna NV; Wozniak P; Collins M
J Clin Psychiatry; 2010 Apr; 71(4):426-32. PubMed ID: 20361904
[TBL] [Abstract][Full Text] [Related]
18. Effectiveness and medical costs of divalproex versus lithium in the treatment of bipolar disorder: results of a naturalistic clinical trial.
Revicki DA; Hirschfeld RM; Ahearn EP; Weisler RH; Palmer C; Keck PE
J Affect Disord; 2005 Jun; 86(2-3):183-93. PubMed ID: 15935238
[TBL] [Abstract][Full Text] [Related]
19. Treatment of Early-Age Mania: Outcomes for Partial and Nonresponders to Initial Treatment.
Walkup JT; Wagner KD; Miller L; Yenokyan G; Luby JL; Joshi PT; Axelson DA; Robb A; Salpekar JA; Wolf D; Sanyal A; Birmaher B; Vitiello B; Riddle MA
J Am Acad Child Adolesc Psychiatry; 2015 Dec; 54(12):1008-19. PubMed ID: 26598476
[TBL] [Abstract][Full Text] [Related]
20. Divalproex versus valproate in patients with bipolar disorder.
Kablinger AS; Czerwinski WP; Minagar A
J Clin Psychopharmacol; 2004 Apr; 24(2):231-2. PubMed ID: 15206673
[No Abstract] [Full Text] [Related]
[Next] [New Search]
